Timing of trialsIn the link below to an article that came out related to this week's press release, Paul said they are commmitted to getting two IND's filed by year-end and will start trials "as early as Q1". I am presuming he means the NASH phase III IND and one cancer IND but I suppose there is some tiny risk he is talking about two cancer IND's getting filed by the end of 2020.
Getting those trials started by the end of March 2021 now looks like the best case scenario with the most likely case being in the second quarter.
My best guess is they are hoping to get both the NASH phase III and the TNBC phase 1 started, present some compelling info at AACR on cancer in April and do a fund raising shortly thereafter as the share price reacts positively to all of that news. Ideally they would wait until they had phase I cancer results to raise money but they would likely have burned through much of what they currently have by then so the rsik of waiting that long would be too great.
https://themarketherald.ca/theratechnologies-announces-new-findings-for-its-lead-investigational-compound-th1902-for-the-treatment-of-several-additional-cancers-2020-12-09/